A clinical study of MK-3508 in healthy people (MK-3508-006)
MK-3508-006
Phase 1 other active
Quick answer
A clinical study of MK-3508 in healthy people (MK-3508-006) for Respiratory syncytial virus infection is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Respiratory syncytial virus infection
- Phase
- Phase 1
- Modality
- other
- Status
- active